123 related articles for article (PubMed ID: 26239996)
21. Extracellular Vesicles from
Aor AC; Sangenito LS; Mello TP; Joffe LS; Rizzo J; Veiga VF; da Silva RN; Pereira MD; Fonseca BB; Rozental S; Haido RMT; Rodrigues ML; Branquinha MH; Santos ALS
J Fungi (Basel); 2024 Apr; 10(4):. PubMed ID: 38667948
[TBL] [Abstract][Full Text] [Related]
22. Development of an immunocompetent murine model of pulmonary infection due to Scedosporium apiospermum.
Luna-Rodríguez CE; Treviño-Rangel RJ; Soto-Domínguez A; Becerril-García MA; González-Montalvo MA; Saldivar M AM; Rodríguez-Rocha H; Gonzalez GM
Microb Pathog; 2020 Feb; 142():104073. PubMed ID: 32070747
[TBL] [Abstract][Full Text] [Related]
23. Tolerability of N-chlorotaurine in comparison with routinely used antiseptics: an in vitro study on chondrocytes.
Pilz M; Staats K; Assadian O; Windhager R; Holinka J
Pharmacol Rep; 2024 May; ():. PubMed ID: 38758471
[TBL] [Abstract][Full Text] [Related]
24. Correction to: The high diversity of Scedosporium and Lomentospora species and their prevalence in human-disturbed areas in Taiwan.
Med Mycol; 2023 Sep; 61(9):. PubMed ID: 37721932
[No Abstract] [Full Text] [Related]
25. Disseminated Lomentospora prolificans infection presenting with multiple cutaneous lesions in an immunocompromised host: A case report and literature review.
Kawamoto M; Kawakami Y; Hirai Y; Kubota S; Fujiwara H; Ueda Y; Anzawa K; Maeda Y; Morizane S
J Dermatol; 2024 Jun; ():. PubMed ID: 38864485
[No Abstract] [Full Text] [Related]
26. Comparative Fungicidal Activities of N-Chlorotaurine and Conventional Antiseptics against
Hacioglu M; Oyardi O; Yilmaz FN; Nagl M
J Fungi (Basel); 2022 Jun; 8(7):. PubMed ID: 35887439
[TBL] [Abstract][Full Text] [Related]
27. Current Opinion on the Therapeutic Capacity of Taurine-Containing Halogen Derivatives in Infectious and Inflammatory Diseases.
Marcinkiewicz J; Nagl M; Kyriakopoulos A; Walczewska M; Skóra M; Skalska P
Adv Exp Med Biol; 2022; 1370():83-98. PubMed ID: 35882784
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Inhaled N-Chlorotaurine in a Mouse Model of
Speth C; Rambach G; Windisch A; Neurauter M; Maier H; Nagl M
J Fungi (Basel); 2022 May; 8(5):. PubMed ID: 35628790
[TBL] [Abstract][Full Text] [Related]
29. N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19)
Lackner M; Rössler A; Volland A; Stadtmüller MN; Müllauer B; Banki Z; Ströhle J; Luttick A; Fenner J; Sarg B; Kremser L; Tone P; Stoiber H; von Laer D; Wolff T; Schwarz C; Nagl M
Emerg Microbes Infect; 2022 Dec; 11(1):1293-1307. PubMed ID: 35418279
[No Abstract] [Full Text] [Related]
30. Activity of
Grimus V; Coraça-Huber DC; Steixner SJM; Nagl M
Antibiotics (Basel); 2021 Jul; 10(8):. PubMed ID: 34438941
[No Abstract] [Full Text] [Related]
31. N-chlorotaurine, a potent weapon against multiresistant bacteria.
Anich C; Orth-Höller D; Lackner M; Nagl M
J Appl Microbiol; 2021 Oct; 131(4):1742-1748. PubMed ID: 33638897
[TBL] [Abstract][Full Text] [Related]
32. Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis.
Schwarz C; Hartl D; Eickmeier O; Hector A; Benden C; Durieu I; Sole A; Gartner S; Milla CE; Barry PJ
Mycopathologia; 2018 Feb; 183(1):21-32. PubMed ID: 28762125
[TBL] [Abstract][Full Text] [Related]
33. N-Chlorotaurine, a Promising Future Candidate for Topical Therapy of Fungal Infections.
Nagl M; Arnitz R; Lackner M
Mycopathologia; 2018 Feb; 183(1):161-170. PubMed ID: 28702855
[TBL] [Abstract][Full Text] [Related]
34. Microbicidal activity of N-chlorotaurine in combination with hydrogen peroxide.
Mustedanagic J; Ximenes VF; Nagl M
AMB Express; 2017 Dec; 7(1):102. PubMed ID: 28545261
[TBL] [Abstract][Full Text] [Related]
35. N-Chlorotaurine Exhibits Fungicidal Activity against Therapy-Refractory Scedosporium Species and Lomentospora prolificans.
Lackner M; Binder U; Reindl M; Gönül B; Fankhauser H; Mair C; Nagl M
Antimicrob Agents Chemother; 2015 Oct; 59(10):6454-62. PubMed ID: 26239996
[TBL] [Abstract][Full Text] [Related]
36. Bactericidal and Fungicidal Activity of
Gruber M; Moser I; Nagl M; Lackner M
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223376
[TBL] [Abstract][Full Text] [Related]
37. Conidial germination in Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans: influence of growth conditions and antifungal susceptibility profiles.
Mello TP; Aor AC; Oliveira SS; Branquinha MH; Santos AL
Mem Inst Oswaldo Cruz; 2016 Jun; 0(7):0. PubMed ID: 27355215
[TBL] [Abstract][Full Text] [Related]
38.
Furnica DT; Dittmer S; Scharmann U; Meis JF; Steinmann J; Rath PM; Kirchhoff L
Microbiol Spectr; 2023 Jun; 11(3):e0513022. PubMed ID: 37017567
[TBL] [Abstract][Full Text] [Related]
39. Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi.
Wiederhold NP; Lewis RE
Med Mycol; 2009 Jun; 47(4):422-32. PubMed ID: 19058049
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
